July 24 (Reuters) - Edwards Lifesciences Corp ( EW ):
* EDWARDS LIFESCIENCES EXPANDS STRUCTURAL HEART PORTFOLIO
WITH
ACQUISITIONS OF JENAVALVE AND ENDOTRONIX
* EDWARDS LIFESCIENCES CORP ( EW ) - AGGREGATE UPFRONT PURCHASE
PRICE FOR
THESE STRATEGIC INVESTMENTS IS APPROXIMATELY $1.2 BILLION
* EDWARDS LIFESCIENCES CORP ( EW ): ANTICIPATES FDA APPROVAL OF
JENAVALVE
TRILOGY HEART VALVE SYSTEM IN LATE 2025
Source text for Eikon:
Further company coverage: